| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,761,000 | 1,529,000 | 1,552,000 | 1,962,000 | | Cost of Revenue |
-
| 417,000 | 1,531,000 | (20,000) | | | Gross Profit | 1,761,000 | 1,112,000 | 21,000 | 1,982,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,068,000 | 948,000 | (195,000) | 1,275,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 286,000 | 395,000 | 240,000 | 144,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 407,000 | (231,000) | (24,000) | 563,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 407,000 | (231,000) | (24,000) | 563,000 | | Interest Expense | 273,000 | 410,000 | 138,000 | 326,000 | | Income Before Tax | 134,000 | (641,000) | (162,000) | 237,000 | | Income Tax Expense | 18,000 | (272,000) | (92,000) | 27,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 116,000 | (369,000) | (70,000) | 210,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 116,000 | (369,000) | (70,000) | 210,000 | | Preferred Stock And Other Adjustments | 14,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $130,000 | ($369,000) | ($70,000) | $210,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
